Friedreich Ataxia Trial, Recruiting (NCT05943002)

Friedreich Ataxia Trial, Recruiting NCT05943002 Sponsor: German Center for Neurodegenerative Diseases (DZNE) Condition: Friedreich Ataxia

Printed from Voxsanity (voxsanity.com.au) — NCT05943002 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Friedreich Ataxia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Friedreich's Ataxia (FA) confirmed through genetic testing
Your ataxia (loss of coordination) is rated at 30 points or below on a standard medical scale used to measure ataxia severity (called the SARA scale)
You have access to a smartphone or tablet and are able to use it
You are older than 12 years of age

Who may not be able to join:

You are not able to give your own consent to take part in the trial
Your ataxia is rated above 30 points on the standard ataxia severity scale (called the SARA scale)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bernhard Michalowsky, PD Dr., German Center for Neurodegenerative Diseases (DZNE) Rostock/ Greifswald, Germany

Phone: +49 3834 868530

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05943002

Sponsor: German Center for Neurodegenerative Diseases (DZNE)

Phase: Not Applicable

Status: Recruiting

Condition: Friedreich Ataxia

Trial contact: +49 3834 868530

More information: https://clinicaltrials.gov/study/NCT05943002

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Friedreich's Ataxia (FA) confirmed through genetic testing
Your ataxia (loss of coordination) is rated at 30 points or below on a standard medical scale used to measure ataxia severity (called the SARA scale)
You have access to a smartphone or tablet and are able to use it
You are older than 12 years of age

Who may not be able to join:

You are not able to give your own consent to take part in the trial
Your ataxia is rated above 30 points on the standard ataxia severity scale (called the SARA scale)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

German Center for Neurodegenerative Diseases (DZNE)

Registry

ClinicalTrials.gov

Start date

1 June 2023

Est. completion

30 June 2028

Where this trial is recruiting

🇦🇹 Austria 🇫🇷 France 🇩🇪 Germany

Primary endpoints

Usability of the mobile-health app as a remote monitoring momentary data assessment tool; Acceptability of the mobile-health app as a remote monitoring momentary data assessment tool; Total societal costs; Health-related quality of life; Health-related quality of life; Health-related quality of life; Health-related quality of life; Psychosocial health due to communication handicaps caused by speech and hearing disabilities; Psychosocial health due to communication handicaps caused by speech and hearing disabilities; Psychosocial health due to communication handicaps caused by speech and hearin...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov